XTX Topco’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$587K	Buy	214,231 +52,257	+32%	+$165K	0.01%	1888
2025 Q4	$599K	Buy	+161,974	New	+$523K	0.02%	1444
2025 Q1	–	Sell	-24,494	Closed	-$53.9K	–	2588
2024 Q4	$53.9K	Sell	24,494 -131,806	-84%	-$308K	﹤0.01%	1884
2024 Q3	$258K	Sell	156,300 -208,381	-57%	-$421K	0.02%	1288
2024 Q2	$810K	Buy	364,681 +321,859	+752%	+$757K	0.07%	441
2024 Q1	$115K	Buy	+42,822	New	+$104K	0.02%	1337
2023 Q4	–	Sell	-519,129	Closed	-$509K	–	1733
2023 Q3	$509K	Buy	519,129 +102,377	+25%	+$148K	0.09%	391
2023 Q2	$579K	Buy	416,752 +106,971	+35%	+$149K	0.1%	285
2023 Q1	$493K	Buy	+309,781	New	+$1.6M	0.1%	301
2022 Q2	–	Sell	-18,686	Closed	-$87K	–	922
2022 Q1	$87K	Buy	+18,686	New	+$80.2K	0.04%	534